E Mohamadi, Gh Moradi, F Nasresfahani, Mitra Hakim Shooshtari,
Volume 3, Issue 3 (8-2017)
Abstract
Background and Objectives: Although Up to 90% of adolescents with attention deficit-hyperactivity disorder (ADHD) remain functionally impaired, but less than half continue to take medication. In developing countries little is known about factors influencing willingness to use the treatment. This paper has assessed views on willingness to use treatment in groups involved in ADHD.
Methods: 17 adolescents with ADHD referred to Tehran Psychiatric Institute participated in this qualitative study by available sampling .Focus Group discussions (FGD) were conducted in two groups of adolescents and two groups of their parents and teachers. Deep interviews were done with two pediatricians and data analyzed with Content analysis method.
Results: The most important factors influenced willingness to use the treatment, in all of groups consist of side-effects expectations, concerns regarding social stigma of medication, incorrect perceptions and low knowledge about ADHD and its treatment, cost and unavailability of treatment options. All groups confirm effectiveness of medications but adolescents had lowest willingness to use the treatment.
Conclusion: Involvement of adolescents in treatment decision-making may increase willingness to use the treatment. Totally, despite of all treatment obstacles, all of the groups accepted medication is inevitable.
Mehrnoosh Pourfallah,
Volume 6, Issue 2 (8-2020)
Abstract
Neonatal hypertension is a rare and complex condition, with an incidence rate of 0.2% to 3%. It can be resulted by several risk factors such as renal diseases, use of several drugs, neurologic, cardiac, respiratory and endocrine causes. Gestational age, birth weight and conceptual age are the most important risk factors. Renal diseases can be found in about 25% to 50% of hypertension at neonatal intensive care units (NICU). The diagnostic of neonatal hypertension is not easy because its symptoms are often non-specific. Hypertension usually discovered on routine monitoring of vital signs. Physical examination and clinical history of neonates along with laboratory diagnostic tests and imaging studies are necessary for the identification of the disease. Calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, α- and β-blockers, vasodilators, and diuretics are the most commonly used antihypertensive agents in NICU. Surgical interventions are uncommon; however, they are valuable in cases with secondary hypertension. This review aimed to discuss recent data on the etiology, accurate diagnosis and treatment of neonatal hypertension.